一种营养配方粉对肿瘤患者营养治疗效果的临床观察

doi:10.16689/j.cnki.cn11-9349/r.2020.03.016

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (2398 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To investigate a nutritional improvement effect of functional food on patients with malignant tumors. Methods A total of 248 patients with tumor admitted to 10 hospitals from April to October 2019 were selected and were divided into the control group (154 patients) and the functional group (94 patients). They all received radiotherapy or chemotherapy. Tumor patients in the functional group taking 30g of functional nutrition powder in the morning and evening were divided into four groups according to different durations： 9 in group A (15-30d), 25 in group B (31-60d), 44 in group C (61-90d), 16 in Group D (≥90d). The other 154 patients received radiotherapy or chemotherapy as the control group not taking functional food. During the experiment, relevant clinical indicators of patients were collected to evaluate the safety and patient compliance of functional food, and the physical strength, overall quality of life score, appetite score, white blood cell count, body weight, serum albumin level and other nutritional status indicators of each group before and after treatment were recorded and analyzed. Results Compared with the control group, the patients who took functional food had better nutrition indicators such as white blood cell weight and albumin, as well as physical life quality and appetite. After taking functional food for 1month, most of the tumor patients could maintain the normal levels of white blood cells and albumin. The average weight of the nutrition group was maintained at the pre-chemoradiotherapy level and higher than that of the control group (no statistical significance). The effect of the nutrition powder on the physical strength and overall quality of life of patients with gastrointestinal tumors was more significant. Conclusion The functional food can significantly improve the nutritional status of malignant tumor patients, good safety, can be used as an adjuvant anti-tumor therapy.

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	Liu Meng
	Shi Hanping
	Zhou Hebing
	Wan Chunfu
	Fang Yu

Cite this article:

Liu Meng,Shi Hanping,Zhou Hebing, et al. Clinical observation on the effect of functional food on nutritional therapy of cancer patients[J]. Electron J Metab Nutr Cancer, 2020, 7(3): 333-339.

URL:

http://182.92.200.144/EN/10.16689/j.cnki.cn11-9349/r.2020.03.016 OR http://182.92.200.144/EN/Y2020/V7/I3/333

1.GABRIELSON D K, SCAFFIDI D, LEUNG E, et al. Use of an abridged scored patient-generated subjective global assessment (abPG-SGA) as a nutritional screening tool for cancer patients in an outpatient setting［J］. Nutr Cancer, 2013, 65(2):234-239.
2.石汉平, 贾平平. 我国肿瘤营养事业的发展与挑战［J］. 首都医科大学学报, 2019, 40(2):159-162.
3.JEAN L, MEGAN W B. The rationale for a role for diet and nutrition in the prevention and treatment of cancer［J］. Eur J Cancer Prev, 2018, 27(4):406-410.
4.BALDWIN C. The effectiveness of nutritional interventions in malnutrition and cachexia［J］. Proc Nutr Soc, 2015, 74(4):397-404.
5.BAIL J, MENESES K, DEMARK-WAHNEFRIED W. Nutritional status and diet in cancer prevention［J］. Semin Oncol Nurs, 2016, 32(3):206-214.
6.YALCIN S, GUMUS M, OKSUZOGLU B, et al. Nutritional aspect of cancer care in medical oncology patients［J］. Clin Ther, 2019, 41(11):2382-2396.
7.GRLEK GKEBAY D, EMIR S, BAYHAN T, et al. Assessment of nutritional status in children with cancer and effectiveness of oral nutritional supplements［J］. Pediatr Hematol Oncol, 2015, 32(6):423-432.
8.姜锦锦,胡海峰,张奇,等. 特医食品对荷肝癌小鼠化疗时营养状况的影响［J］.食品科技, 2018, 43(7):45-48.
9.王春颖,李晓军,马跃英, 等.特殊医学用途配方食品的现状分析［J］.农产品加工, 2018, (11):63-67, 70.
10.程义勇. 《中国居民膳食营养素参考摄入量》2013修订版简介［J］.营养学报, 2014,36(4):313-317.
11.李增宁,陈伟,齐玉梅,等.肿瘤患者特殊医学用途配方食品应用专家共识［J］. 肿瘤代谢与营养电子杂志, 2016, 3(2):95-99.
12.SOGA T. Cancer metabolism: key players in metabolic reprogramming［J］. Cancer Sci, 2013, 104(3):275-281.
13.FERREIRA L M. Cancer metabolism: the Warburg effect today［J］. Exp Mol Pathol, 2010, 89(3):372-380.
14.WANG C, PENG R, WANG L, et al. Wushen, a food mixture containing 55 different natural ingredients, inhibits S180 tumor growth in vivo［J］. Food Funct, 2014, 5(7):1475-1480.
15.YOSHIDA G J. Metabolic reprogramming: the emerging concept and associated therapeutic strategies［J］. J Exp Clin Cancer Res Cr, 2015, 34:111.
16.PHAN L M, YEUNG S C, LEE M H. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies［J］. Cancer Biol Med, 2014, 11(1):1-19.
17.WARD P S, THOMPSON C B. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate［J］. Cancer Cell, 2012, 21(3):297-308.
18.MAAN M, PETERS J M, DUTTA M, et al. Lipid metabolism and lipophagy in cancer［J］. Biochem Biophys Res Commun, 2018, 504(3):582-589.
19.CHO E, HOLMES M, HANKINSON S E, et al. Nutrients involved in one-carbon metabolism and risk of breast cancer among premenopausal women［J］. Cancer Epidemiol Biomarkers Prev, 2007, 16(12):2787-2790.
20.STEVENS V L, MCCULLOUGH M L, SUN J, et al. Folate and other one-carbon metabolism-related nutrients and risk of postmenopausal breast cancer in the Cancer Prevention Study II Nutrition Cohort［J］. Am J Clin Nutr, 2010, 91(6):1708-1715.
21.KAWADA J, NISHINO M, HATA T, et al. Analysis of patients who received enteral nutrition in the course of chemotherapy［J］. Gan To Kagaku Ryoho, 2017, 44(10):900-902.
22.OKADA T, NAKAJIMA Y, NISHIKAGE T, et al. A prospective study of nutritional supplementation for preventing oral mucositis in cancer patients receiving chemotherapy［J］. Asia Pac J Clin Nutr, 2017, 26(1):42-48.
23.LIU H, LING W, SHEN Z Y, et al. Clinical application of immune-enhanced enteral nutrition in patients with advanced gastric cancer after total gastrectomy［J］. J Dig Dis, 2012, 13(8):401-406.
24.WEIMIN G, EUNHEE K, MOHSEN M. Nutrition and Cancer［J］. Nutr Cancer, 2009, 61(6):807-810.
25.GARFINKEL L. Nutrition and cancer: current status［J］. CA Cancer J Clin. 1991, 41(6):325-327.
26.SOLHEIM T S, LAIRD BJ A, BALSTAD T R, et al. Cancer cachexia: rationale for the MENAC (multimodal-exercise, nutrition and anti-inflammatory medication for cachexia) trial［J］. BMJ Support Palliat Care, 2018, 8(3):258-265.
27.IMOBERDORF R, RHLIN M, BALLMER P E. Cancer and nutrition-a paradigma shift［J］. Laryngorhinootologie, 2017, 96(8):514-518.
28.JORDAN T, MASTNAK D M, PALAMAR N, et al. Nutritional therapy for patients with esophageal cancer. Nutr Cancer, 2018, 70(1):23-29.
29.SADEGHI M, KESHAVARZ-FATHI M, BARACOS V, et al. Cancer cachexia: diagnosis, assessment, and treatment［J］. Crit Rev Oncol Hematol, 2018, 127:91-104.
30.SHEN G, HUANG J Y, HUANG Y Q, et al. The Relationship between telomere length and cancer mortality: data from the 1999-2002 National Healthy and Nutrition Examination Survey (NHANES) ［J］. J Nutr Health Aging, 2020, 24(1):9-15.
31.赵祯,李东,刘玉峰,等. 一种全息营养配方粉的营养及功效成分分析［J］.肿瘤代谢与营养电子杂志, 2019, 6(4):430-435.